Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
about
Diagnosis and subclassification of acute lymphoblastic leukemiaManagement of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.Treatment of adolescent and young adults with acute lymphoblastic leukemiaPrognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia.Genomic characterization of acute leukemias.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Clonal evolution in therapy-related neoplasms.Cesarean Section and Risk of Childhood Acute Lymphoblastic Leukemia in a Population-Based, Record-Linkage Study in California.BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan.Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.Lymphoblastic lymphoma presenting as bilateral renal enlargement diagnosed by percutaneous kidney biopsy: Report of three cases.Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups.Canine acute leukaemia: 50 cases (1989-2014).p53 pathway dysfunction in AML: beyond TP53 mutations.Treatment of Older Patients with Acute Lymphoblastic Leukaemia.An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database.10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.Oral and maxillofacial pathologies in young- and middle-aged adults.
P2860
Q26824387-BB346FED-A27E-4FBA-9A12-9882941E8BC6Q33762835-5B5B279B-6A46-47C2-BC52-EE1AB7AE6376Q33822032-E146DFE4-8561-434D-A4DE-F657545401F4Q33828594-ECB0FD5C-BBE3-435E-AF4D-A6176D0A8C9AQ33920153-328C41DE-27EC-4082-8965-37502ACFF2FBQ35986474-9E4A5F00-5AD4-4FAC-9BF7-F796B22A7498Q37322860-0E010DDA-B8D0-43A1-B026-C9BBB0C21992Q38223490-7B412560-B203-4D12-A962-FDDE3EAD6EC2Q38264774-AAA8B7AB-CA94-4862-97FB-3F6E0926FABDQ39026726-D4D4D4A7-AE02-42C6-A2AB-FE96C02E8059Q39093611-B654AA04-68EC-4551-9F64-BFB9D2059ED4Q39122060-213D7CDF-4C2A-4686-8799-E871C429844AQ39992854-A0240D53-2D9F-4A93-A6FE-7253EA8BB759Q40179856-EA60CA4A-AEA1-4BFE-AEDF-742101342F35Q40532933-886929B8-A3D0-4A94-A92C-613BB23903CFQ41490108-A71408F5-3986-4343-997D-E6AE13B427E3Q42396923-6DB21669-8E64-4D33-8FDB-40B90CC2A6AFQ42660203-4C12BC88-C7D7-4C70-BD60-F4933430E13EQ44865468-996C6759-1548-42BF-9112-E97ECCB2B4E0Q47266463-9EFC2DFD-3941-4601-A71C-006579D4F4D9Q47774455-5B2F9F86-CD68-4ED6-BE44-83ADBB4050C2Q47955491-BEB32799-07D6-4CF3-9488-B8818855F146Q48154770-CA56FE62-EEBF-4A2F-9C39-550CBFA3364FQ48213171-957201AF-2DA2-449D-821C-C90576903D88Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658Q53646394-DD2A4904-00A1-4C2D-9B40-071607475AD3
P2860
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinico-biological features of ...... and stratified in age cohorts
@en
Clinico-biological features of ...... and stratified in age cohorts.
@nl
type
label
Clinico-biological features of ...... and stratified in age cohorts
@en
Clinico-biological features of ...... and stratified in age cohorts.
@nl
prefLabel
Clinico-biological features of ...... and stratified in age cohorts
@en
Clinico-biological features of ...... and stratified in age cohorts.
@nl
P2093
P2860
P50
P921
P1433
P1476
Clinico-biological features of ...... and stratified in age cohorts
@en
P2093
Alessandra Tedeschi
Andrea Biondi
Anna Guarini
Anna Maria Testi
Antonella Vitale
Daniela Silvestri
Felicetto Ferrara
Francesca Mancini
Francesco Fabbiano
Franco Mandelli
P2860
P304
P356
10.3324/HAEMATOL.2012.080432
P577
2013-05-28T00:00:00Z